Which factors can affect transporters at the blood–tissue junction and thereby influence distribution?

• A. Saturation and competition
• B. Temperature and pH
• C. Protein binding and lipophilicity
• D. Renal clearance and metabolism

Answer: (A)

Transporter-mediated distribution across blood–tissue barriers is often governed by saturable, carrier-mediated processes. There are only finite transporter molecules, so as drug concentration rises, the transport rate reaches a maximum and cannot increase further—this is saturation. If two drugs rely on the same transporter, they compete for it; this competition can reduce the transport rate of one or both drugs, altering how much drug enters into tissues or is cleared, and thereby changing tissue distribution. This combination explains why distribution can show nonlinear behavior and be sensitive to drug–drug interactions at transporters.

Other factors like temperature and pH can modulate transporter activity to some extent, but they are less central to the concept of transporter-limited distribution. Protein binding and lipophilicity mainly influence passive diffusion and overall distribution magnitude, not the transporter capacity. Renal clearance and metabolism affect elimination from the body rather than the transporter step at the blood–tissue junction.